We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BFRA market cap is 170.36M. The company's latest EPS is EUR -0.0058 and P/E is -10408.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 7.02M | 7.45M | 3.71M | 3.49M | 3.52M |
| Operating Income | -2.42M | 2.5M | -2.7M | -2.64M | -290k |
| Net Income | -3.14M | 5.92M | -2.71M | -2.64M | -264k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 31.27M | 30.35M | 28.79M | 25.74M | 32.25M |
| Operating Income | -2.19M | -10.03M | 39.39M | -43.05M | -2.13M |
| Net Income | -7.36M | -13.02M | 37.75M | -44.17M | -369k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 24.02M | 30.73M | 28.04M | 24.18M | 23.06M |
| Total Liabilities | 10.13M | 10.75M | 10.78M | 6.32M | 6.1M |
| Total Equity | 13.89M | 19.98M | 17.26M | 17.86M | 16.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 58.36M | 56.39M | 76.13M | 32.73M | 30.73M |
| Total Liabilities | 48.41M | 49.02M | 18.7M | 12.39M | 10.75M |
| Total Equity | 9.96M | 7.38M | 57.43M | 20.34M | 19.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | -1.91M | N/A | -3.82M | N/A |
| Investing | N/A | -912k | N/A | -27k | N/A |
| Financing | N/A | -479k | N/A | 2.98M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -32.89M | -2.85M | 30.44M | -3.9M | -1.91M |
| Investing | 21.05M | 2.87M | -42.26M | -981k | -912k |
| Financing | 3.46M | 5.95M | 2.18M | 4.34M | -479k |
| Market Cap | 170.36M |
| Price to Earnings Ratio | -10408.62 |
| Price to Sales Ratio | 119.45 |
| Price to Cash Ratio | 1.25k |
| Price to Book Ratio | 192.79 |
| Dividend Yield | - |
| Shares Outstanding | 63.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.41 (14.04%) |
| Company Name | Biofrontera AG |
| Address |
hemmelrather weg 201 leverkusen 51377 |
| Website | https://www.biofrontera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
